An implant is a medical device that is surgically transplanted in the body to replace or support damaged body organs, enhance their functionalities, or detect flaws in functioning of organs. Medical devices can be placed either permanently or temporarily in the body, and can be removed when they are time-worned. These implantable devices are composed of bones, tissues, skin, ceramics, metals, and other natural materials.
Check the DISCOUNT on this report @ http://www.orbisresearch.com/contacts/discount/215602 .
The global implantable medical devices market was valued at $72,265 million in 2015, and is estimated to reach $116,300 million by 2022, registering a CAGR of 7.1% during the forecast period. The market is driven by factors such as rise in prevalence of chronic diseases and rapid increase in geriatric population. Moreover, increased awareness among individuals and rapid technological advancements in the medical implants sector fuel the market growth. However, high cost of implantation and dearth of skilled workforce hamper the market growth. Even then, this market is poised to grow at a CAGR of 10.7% from 2016 to 2022 (in terms of volume).
The global implantable medical devices market is segmented based on product type and geography. Based on product type, the market is categorized into orthopedic implants, dental implants, breast implants, cardiovascular implants, intraocular lenses, and other implants. The orthopedic implants segment contributed the highest revenue to the global market in 2015, owing to the large pool of patients undergoing orthopedic implants due to hyperactive lifestyle, unhealthy food habits, rise in geriatric population, and advancements in medical technologies. The other implants category was the fastest growing segment in 2015, due to increase in prevalence of neurological diseases, craniomaxillofacial deformities, and eye disorders; increase in the rate of cosmetic surgeries; and rise in geriatric population.
The market is segmented on the basis of four regions, namely North America, Europe, Asia-Pacific, and LAMEA. North America held the largest share (nearly half) in the global implantable medical devices market in 2015 due to advancements in implantable medical devices and increase in prevalence of chronic diseases.
The Asia-Pacific region is expected to grow at the highest CAGR of 9.1% during the forecast period. The developing countries in the Asia-Pacific region, such as China and India, provide significant growth opportunities to market players, owing to the large population base and increase in awareness about the benefits of medical implants. Moreover, the report provides comprehensive analyses of the key players operating in the implantable medical devices market.
Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/215602 .
The study provides in-depth analyses of the global implantable medical devices market along with the current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis for the period of 2014–2022 to enable stakeholders to capitalize on the prevailing opportunities in the industry.
Extensive analysis of the global market helps in understanding the different types of devices used in the treatment of chronic diseases and other cardiac conditions.
Competitive intelligence of market players highlights the business practices and trends across various regions.
Key Market Segments
The global implantable medical devices market is segmented based on product type and geography.
Reconstructive Joint Replacement
Rest of Europe
Rest of Asia-Pacific
For more information contact firstname.lastname@example.org
Some Point’s from Table of Content:
Chapter: 1. Introduction
1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2. Executive Summary
2.1. Key findings of the study
2.2. CXO perspective
Chapter: 3. Market Overview
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
18.104.22.168. Competitive intelligence of companies and their strategies
3.3. Porters five forces analysis
3.3.1. Bargaining power of the suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of new entrants
3.3.4. High intensity of rivalry
3.3.5. Threat of substitutes
3.4. Top Player Positioning, 2015
3.5. Market dynamics
22.214.171.124. Growing elderly population and rise in prevalence of chronic diseases
126.96.36.199. Technological advancements in the field of implantable medical devices
188.8.131.52. Global rise in acceptance of implantable medical devices
184.108.40.206. Improvement of healthcare infrastructure in developing countries
220.127.116.11. Better insurance and reimbursement
18.104.22.168. Increasing government focus on funding R&D initiatives
22.214.171.124. Rising number of FDA approvals for performing clinical trials to benefit the market
126.96.36.199. High cost of treatment associated with implantable medical devices
188.8.131.52. Stringent approval process as these are highly specialized devices
184.108.40.206. Huge market opportunities in the APAC region and developing countries
220.127.116.11. Increasing awareness amongst patients and increasing preference for a better quality of life
18.104.22.168. Increase in development of minimally invasive and non-surgical procedures
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/215602 .
For any enquires before buying, connect with us @ email@example.com